Related content

Cholinergic receptors and neurodegenerative diseases

By Gualtieri F.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Receptors in neurodegenerative diseases, muscarinic cholinergic receptors

By Angeli P.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite

Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 11, Iss. 1, 2012-06 ,pp. : 20-36

Bentham Science Publishers

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of neurodegenerative diseases

By Maimone D.   Dominici R.   Grimaldi L.M.E.  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 11-29

Elsevier

Access to resources Recommend Favorite